Importance measures are integral parts of risk assessment for risk‐informed decision making. Because the parameters of a risk model, such as the component failure rates, are functions of time and a perturbation (change) in their values can occur during the mission time, time dependence must be considered in the evaluation of the importance measures. In this paper, it is shown that the change in system performance at time t, and consequently the importance of the parameters at time t, depends on the parameters perturbation time and their value functions during the system mission time. We consider a nonhomogeneous continuous time Markov model of a series‐parallel system to propose the mathematical proofs and simulations, while the ideas are also shown to be consistent with general models having nonexponential failure rates. Two new measures of importance and a simulation scheme for their computation are introduced to account for the effect of perturbation time and time‐varying parameters.
Importance measures (IMs) are used for risk-informed decision making in system operations, safety, and maintenance. Traditionally, they are computed within fault tree (FT) analysis. Although FT analysis is a powerful tool to study the reliability and structural characteristics of systems, Bayesian networks (BNs) have shown explicit advantages in modeling and analytical capabilities. In this paper, the traditional definitions of IMs are extended to BNs in order to have more capability in terms of system risk modeling and analysis. Implementation results on a case study illustrate the capability of finding the most important components in a system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.